Your browser doesn't support javascript.
loading
Shattering barriers toward clinically meaningful MSC therapies.
Levy, Oren; Kuai, Rui; Siren, Erika M J; Bhere, Deepak; Milton, Yuka; Nissar, Nabeel; De Biasio, Michael; Heinelt, Martina; Reeve, Brock; Abdi, Reza; Alturki, Meshael; Fallatah, Mohanad; Almalik, Abdulaziz; Alhasan, Ali H; Shah, Khalid; Karp, Jeffrey M.
Afiliação
  • Levy O; Center for Nanomedicine and Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA.
  • Kuai R; Center for Nanomedicine and Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA.
  • Siren EMJ; BWH Center of Excellence for Biomedicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Bhere D; Center for Nanomedicine and Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA.
  • Milton Y; BWH Center of Excellence for Biomedicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Nissar N; Center for Stem Cell Therapeutics and Imaging, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • De Biasio M; Center for Nanomedicine and Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA.
  • Heinelt M; Center for Stem Cell Therapeutics and Imaging, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Reeve B; Center for Nanomedicine and Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA.
  • Abdi R; Center for Nanomedicine and Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA.
  • Alturki M; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.
  • Fallatah M; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Almalik A; National Center of Pharmaceutical Technology, Life Science and Environment Research Institute, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.
  • Alhasan AH; KACST Center of Excellence for Biomedicine, Joint Centers of Excellence Program, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.
  • Shah K; KACST Center of Excellence for Biomedicine, Joint Centers of Excellence Program, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.
  • Karp JM; National Center of Pharmaceutical Technology, Life Science and Environment Research Institute, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.
Sci Adv ; 6(30): eaba6884, 2020 07.
Article em En | MEDLINE | ID: mdl-32832666

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus / Transplante de Células-Tronco Mesenquimais / Células-Tronco Mesenquimais / Betacoronavirus Limite: Humans Idioma: En Revista: Sci Adv Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus / Transplante de Células-Tronco Mesenquimais / Células-Tronco Mesenquimais / Betacoronavirus Limite: Humans Idioma: En Revista: Sci Adv Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos